WLWeimiao Li

Weimiao Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weimiao Li has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Jianyuan Gao

    Department of Geriatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China

    1 shared publication
  • Shouyin Di

    Department of Geriatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China

    1 shared publication
  • Wei Hu

    Department of Immunology, The Fourth Military Medical University, Xi'an, China

    1 shared publication
  • Xiaofei Li

    Department of Thoracic Surgery, Tangdu Hospital, the Fourth Military Medical University, Xi'an, China

    1 shared publication
  • Xiaolong Yan

    Department of Thoracic Surgery, Tangdu Hospital, the Fourth Military Medical University, Xi'an, China

    1 shared publication
  • Zheng Wang

    Department of Cardiothoracic Surgery, Central Theater Command General Hospital of Chinese People's Liberation Army, Wuhan, China

    1 shared publication

Latest Publications

  • Open Access

    The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy

    by Shouyin Di, Zheng Wang, Wei Hu, Xiaolong Yan, Zhiqiang Ma, Xiaofei Li, Weimiao Li, Jianyuan Gao

    Aim: Melatonin is an indolamine secreted by the pineal gland, as well as most of the organs and tissues. In addition to regulating circadian biology, studies have confirmed the multiple pharmacological effects of melatonin. Melatonin provides a strong defense against septic myocardial injury. However, the underlying mechanism has not been fully described. In this study, we investigated the protective effects of melatonin against lipopolysaccharide (LPS)-induced myocardial injury as well as the mechanisms involved. Methods: Mice were intraperitoneally injected with LPS to induce a septic myocardial injury model or an LPS shock model, depending on the dose of LPS. Melatonin was given (20 mg/kg/day, via intraperitoneal injection) for a week prior to LPS insult. 6 h after LPS injection, echocardiographic analysis, TUNEL staining, transmission electron microscopy (TEM), western blot, quantitative real-time PCR and ELISA were used to investigate the protective effects of melatonin against LPS induced myocardial injury. AMPK inhibitor, autophagy activator and inhibitor, siRNAs were used for further validation. Results: Survival test showed that melatonin significantly increased the survival rate after LPS-induced shock. In the sepsis model, melatonin markedly ameliorated myocardial dysfunction, decreased the release of inflammatory cytokines, activated AMP-activated protein kinase (AMPK), improved mitochondrial function, and activated autophagy. To confirm whether the protection of melatonin was mediated by AMPK and autophagy, Compound C, an AMPK inhibitor; 3-MA, an autophagy inhibitor; and Rapamycin (Rapa), an autophagy activator, were used in this study. AMPK inhibition down-regulated autophagy, abolished protection of melatonin, as indicated by significantly decreased cardiac function, increased inflammation and damaged mitochondrial function. Furthermore, autophagy inhibition by 3-MA significantly impaired the protective effects of melatonin, whereas autophagy activation by Rapa reversed LPS + Compound C induced myocardial injury. In addition, in vitro studies further confirmed the protection of melatonin against LPS-induced myocardial injury and the mechanisms involving AMPK-mediated autophagy signaling. Conclusions: In summary, our results demonstrated that melatonin protects against LPS-induced septic myocardial injury by activating AMPK mediated autophagy pathway.